7481 - 7490 of 8808 Results
Title
Year
-
OPENTitle: Improvement of dyskinesias withl-dopa infusion in advanced Parkinson's diseaseJournal Name: Acta Neurologica ScandinavicaPublisher: WileyVol: 133Issue #: 6Start Page: 451End Page: 458Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ane.12483Best OA location URL: http://www.scopus.com/inward/record.url?scp=84941312569&partnerID=8YFLogxKCitation Count: 26
-
OPENTitle: Explainable classification of Parkinson’s disease using deep learning trained on a large multi-center database of T1-weighted MRI datasetsJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 38Issue #:Start Page: 103405End Page: 103405Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2023.103405Best OA location URL: https://doi.org/10.1016/j.nicl.2023.103405Citation Count: 33
-
OPENTitle: Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's diseaseJournal Name: The FASEB JournalPublisher: WileyVol: 25Issue #: 4Start Page: 1333End Page: 1344Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1096/fj.10-173625Citation Count: 129
- Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial2018OPENTitle: Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 60Issue #:Start Page: 51End Page: 56Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.10.005Best OA location URL: http://www.prd-journal.com/article/S1353802018304310/pdfCitation Count: 17
-
OPENTitle: Association of Sodium–Glucose Cotransporter 2 Inhibitors With Time to Dementia: A Population-Based Cohort StudyJournal Name: Diabetes CarePublisher: American Diabetes AssociationVol: 46Issue #: 2Start Page: 297End Page: 304Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2337/dc22-1705Best OA location URL: https://diabetesjournals.org/care/article-pdf/46/2/297/696578/dc221705.pdfCitation Count: 92
-
RESTRICTEDTitle: Allosteric modulation of mGluR4 as a novel therapeutic direction for the treatment of Parkinson's diseaseJournal Name: The FASEB JournalPublisher: WileyVol: 22Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fasebj.22.1_supplement.103.2Citation Count: 0
-
RESTRICTEDTitle: Response to letter to the Editor: The association between cigarette smoking and dementia with Lewy bodiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 138Issue #:Start Page: 107895End Page: 107895Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107895Citation Count: 0
-
RESTRICTEDTitle: Gene therapy device-based delivery of progranulin, prosaposin, and GDNF as a combined precision and neurorestorative therapy in the rat 6-OHDA model of parkinsonismJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 395Issue #:Start Page: 115474End Page: 115474Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.expneurol.2025.115474Best OA location URL: https://doi.org/10.1016/j.expneurol.2025.115474Citation Count: 0
-
OPENTitle: Episodic memory deficit in HIV infection: common phenotype with Parkinson’s disease, different neural substratesJournal Name: Brain Structure and FunctionPublisher: Springer Science and Business Media LLCVol: 228Issue #: 3-4Start Page: 845End Page: 858Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00429-023-02626-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00429-023-02626-x.pdfCitation Count: 1
- DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers2017OPENTitle: DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriersJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 4Start Page: e0175424End Page: e0175424Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0175424Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0175424&type=printableCitation Count: 33